,
your personalized virtual assistant to find clinical trials. Go head, 
George Y Wu, M.D.
University of Connecticut Health CenterFarmington, Connecticut - 06030 (860-679-2593) |
- CLINICAL TRIALS 1
- CONDITIONS4
- INTERVENTIONS2
- SINCE2007
Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection
December 2007 - October 2012
Hepatitis
Hepatitis, Chronic
Hepatitis C
Hepatitis C, Chronic
Gi-5005
Pegylated Interferon And Ribavirin
